Does the 6% in Medicare Part B drug reimbursement affect prescribing?
It is viewed as a potential incentive to prescribe more expensive drugs when cheaper alternatives exist, as 6% of a high price is more than 6% of a...
It is viewed as a potential incentive to prescribe more expensive drugs when cheaper alternatives exist, as 6% of a high price is more than 6% of a...
Changing the reimbursement amount for medical benefit drugs in the OPPS for hospitals in the 340B program will directly reduce the patient share (set at 20%) for those...
Trade associations and lobbying groups representing cancer physicians and some policymakers regularly state that oncology care costs more in the hospital outpatient department (HOPD) than in the physician...
In four recent letters to CMS, Members of Congress provided conflicting forecasts regarding how the agency’s proposed pilot program of Part B drug payment might affect many aspects...
The “buy and bill” system, the main component under scrutiny, is a reimbursement design in which physicians buy pharmaceutical drugs and submit a bill for reimbursement upon administration...
Partner with Verdant for rigorous, objective economic analysis.